-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Greece's Spyros Doxiadis public health program, which is expected to begin in early 2023, includes free cardiovascular disease prevention and treatment examinations
for all citizens between the ages of 30 and 70, according to the Greek newspaper.
for all citizens between the ages of 30 and 70, according to the Greek newspaper.
The plan will reportedly include screening tests for cardiovascular risk, as well as doctors' assessment of the physical data and disease risk indicators of the person being examined, all at the expense of the state
.
The test includes examination of each person's lipid profile and factors that contribute to diseases such as metabolic syndrome
.
.
The test includes examination of each person's lipid profile and factors that contribute to diseases such as metabolic syndrome
.
The measure benefits Greek citizens and those between the ages of 30 and 70 legally residing in Greece with an AMKA number
.
The total number of beneficiaries is expected to reach 5.
5 million.
.
The total number of beneficiaries is expected to reach 5.
5 million.
It is estimated that 20,000 people in Greece are diagnosed with heart disease problems each year
.
According to a recent report by the Organisation for Economic Co-operation and Development (OECD), 105 deaths per 100,000 people died of coronary heart disease
in 2019.
The EU average is 115 deaths per 100,000 people
.
.
According to a recent report by the Organisation for Economic Co-operation and Development (OECD), 105 deaths per 100,000 people died of coronary heart disease
in 2019.
The EU average is 115 deaths per 100,000 people
.
![benzyl N-{2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethyl}carbamate](https://file.echemi.com/fileManage/upload/goodpicture/20210823/m20210823171124543.jpg)
